Compare Stocks: IPSC vs. FHTX vs. ZNTL vs. CLLS
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IPSCFHTXZNTLCLLS
Market Snapshot
Current market context for the selected companies.
IPSC
$2.13
Market Cap
$392.93M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
FHTX
$6.68
Market Cap
$406.79M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
ZNTL
$3.88
Market Cap
$367.33M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
CLLS
$3.42
Market Cap
$344.40M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | IPSC | FHTX | ZNTL | CLLS |
|---|---|---|---|---|
| 1 Month | +4.1% | +30.3% | -16.0% | +20.4% |
| 1 Month vs SPY | +0.8% | +27.0% | -19.3% | +17.1% |
| 3 Months | -7.4% | +56.6% | -3.5% | -5.8% |
| 3 Months vs SPY | -9.4% | +54.6% | -5.5% | -7.8% |
| 6 Months | -2.1% | +15.3% | +57.1% | -18.2% |
| 6 Months vs SPY | -12.5% | +4.8% | +46.6% | -28.6% |
| 1 Year | +317.8% | +27.3% | +113.2% | +27.1% |
| 1 Year vs SPY | +298.7% | +8.2% | +94.0% | +8.0% |
| 2 Years | +19.3% | -9.7% | +17.6% | +45.2% |
| 2 Years vs SPY | -17.3% | -46.2% | -19.0% | +8.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.